Pay in 4 interest-free payments of $6.78 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
Got my rx quickly and customer service is always available to speak with for concerns or questions
AOD-9604 FDA Approval History At a glance FDA approval status / Never approved for any indication in the United States NDA filing history / No New Drug Application has ever been submitted to FDA Chemical identity / Synthetic peptide corresponding to amino acids 176-191 of human growth hormone, with a tyrosine residue added at the C-terminus Developer / Metabolic Pharmaceuticals Ltd (Melbourne, Australia), now defunct Clinical trial outcome / Phase IIb trial (2007) failed to meet primary efficacy endpoint for obesity FDA compounding status / Placed on Category 2 list
The main advantage is that it can be used at short notice, if you need to delay a period that is only a week or two away
The main difference is that AHK-Cu is a synthetic copper peptide
Tendon and ligament endpoints include: tendon fibroblast outgrowth collagen fibre organisation histology scoring gap closure markers growth hormone receptor expression angiogenesis markers mechanical strength style readouts cell migration markers This makes BPC-157 Research Peptide a key compound in connective tissue repair research
US$ 21.34
US$ 24.77
US$ 25.70
US$ 27.44
US$ 25.59